ªñ¦~¨Ó·U¨Ó·U¦h®ð³Ý±wªÌ¥X²{Ãþ©T¾J§ÜÃĩʤÏÀ³¡A³o¹ïªø´Á¨Ï¥ÎÃþ©T¾JªvÀø®ð³Ýªº¥Á²³¦Ó¨¥¡A¥i»¡¬O²`¨ü¨äW¡C¤¤¥¡¬ã¨s°|¥Íª«Âå¾Ç¬ì¾Ç¬ã¨s©Ò±i¶®s§U¬ã¨sû¹Î¶¤µo²{¡A²Ä2«¬¥ý¤Ñ§K¬Ì²ÓM¡]group 2 innate lymphoid cell, ILC2¡^»¤µoªº«æ©Ê©I§l¹D§K¬Ì¤ÏÀ³¡A»PÃþ©T¾J§ÜÃÄ©Ê®ð³Ý¬ÛÃö¡C
®ð³Ý¯e¯f¬O¥Ñ©ó§K¬Ì¥¢¿Å©Ò¤Þ°_¡AILC2²ÓM§@¥Î©ó§K¬Ì¨t²Î¤¤¡A·|³Q¹Ð蟎¡BÅðµß»¤µo¬¡¤Æ¡A¶Ç»¼®ð³Ýµoª¢¤ÏÀ³°T®§¡A³y¦¨®ðºÞ¦¬ÁY¡BÂH²G¤Àªc¤®¶iµ¥¯gª¬¡C¬°¤F§í¨îILC2²ÓM¼W¥Í¡A¬ã¨s¹Î¶¤§â±a¦³¡uTLR9°tÅé¡]CpG¡^¡vªº§K¬Ì½Õ±±·L²É¤l¡]microparticle¡^¥H§l¤J¾¯«¬§ëÃÄ¡Aµo²{¦³§U©óªvÀø®ð³Ý¡C¸Ó¬ã¨s¦¨ªG¤w©ó¤µ¡]108¡^¦~3¤ë¥Zµn©ó¡m¹L±Ó©MÁ{§É§K¬Ì¾ÇÂø»x¡n¡]Journal of Allergy and Clinical Immunology¡^¡C
±i¶®sªí¥Ü¡A§K¬Ì½Õ±±·L²É¤l¡]MIS416¡^§t¦³¯à¨ë¿E¤Àªc¤zÂZ¯ÀªºTLR9°tÅé¡]CpG¡^¦¨¤À¡A¬ã¨s¹Î¶¤¥H§l¤J¾¯«¬§ëÃĶi¦æ¦Ñ¹«¹êÅç¡A´Á±æ¦b«I¤J©Ê³Ì¤pªº±¡ªp¤U±NÃĪ«°e¤JªÍ³¡¡Aµo²{¥i§í¨îILC2²ÓM©Ò¾ÉPªº®ð³Ý¯gª¬¡F¹ï©óT²ÓM¾ÉPªº®ð³Ý¯gª¬¤]¦³Àø®Ä¡A¬Û¸û©ó¥Ø«eªºÃþ©T¾J³B¤èÃħó¨ãÀu¶Õ¡C
¦Ó§K¬Ì½Õ±±·L²É¤l¡]MIS416¡^ªº¨Ó·½¬O¨ú¦ÛÚµ½H¤þ»Ä±ìµß¡]Propionibacterium acnes¡^¡A¤]´N¬O¤j®a¼ô±xªº«C¬Kµkµß¡A¥¦§t¦³CpG¦¨¤À¡A¥B¨ã¦³¥Íª«¥i¤À¸Ñ©Ê¡A¹ï©ó¤HÅé¬Û·í¦w¥þ¥B@¨ü©Ê¨}¦n¡C
±i¶®s»¡¡G¡u¹L¥h»{¬°T²ÓM¤~¬O³y¦¨®ð³Ýªº¥D¦]¡A¨Ã¥HÃþ©T¾J§l¤J¾¯ªvÀø¡FÀHµÛ·U¨Ó·U¦hÃþ©T¾J§ÜÃĩʱwªÌ¼W¥[¡A¥»¬ã¨sµo²{ªºILC2²ÓM³Qµø¬°·sªº®ð³ÝªvÀø¼Ðªº¡v¡C¥»¬ã¨s¥H§K¬Ì½Õ±±ªvÀø®ð³Ý¡A¨Ï¥Î±a¦³¡uTLR9°tÅé¡]CpG¡^¡vªº§K¬Ì½Õ±±·L²É¤l¡A¥i¤Àªc¤zÂZ¯À¥H§í¨îILC2²ÓM¶Ç»¼®ð³Ýµoª¢¤ÏÀ³°T®§¡C
¥H§K¬Ì½Õ±±ªvÀø®ð³Ýªº¹B§@ì²z¡A¬O³z¹LÃþÅM¨üÅé¡]TLR9¡^»P°tÅé¡]CpG¡^µ²¦X«á¡A¨ë¿E¡u¼ß²ÓM¼Ë¾ð¬ðª¬²ÓM¡v¡]plasmacytoid dendritic cell, pDC¡^¤Àªc£\«¬¤zÂZ¯À¡]IFN-£\¡^¡F¶i¦Ó¬¡¤Æ¡u¦ÛµM±þ¤â²ÓM¡v¡]NK cell¡^ ¼W¥[£^«¬¤zÂZ¯À¡]IFN-£^¡^¤Àªc¶q¡A¹F¨ì§í¨îILC2²ÓM¼W¥Íªº®ÄªG¡C
°tÅé»P¨üÅ骺µ²¦X¡A¬O¤@ºØ¤À¤lÃѧO¹Lµ{¡C¨üÅé¡]receptor¡^¬O²ÓM½¤¤Wªº¯S®í³J¥Õ¤À¤l¡A¥iÃѧO©M¿ï¾Ü©Ê¦a»P¬Y¨Çª«½èµo¥Í¯S²§©Ê¨üÅéµ²¦X¤ÏÀ³¡A²£¥Í¬ÛÀ³ªº¥Íª«®ÄÀ³¡F°tÅé¡]ligand¡^¬O«ü¤@¨Ç«H¸¹ª«½è¡A°£¤F»P¨üÅéµ²¦X¥~¥»¨¨ÃµL¨ä¥L¥\¯à¡C¬ã¨s¤¤ªºÃþÅM¨üÅé¡]TLR9¡^¦]¨ü¨ì¨ä°tÅé¡]CpG¡^¨ë¿E«á²£¥Íµ²¦X¡A±a¦³¡uTLR9 °tÅé¡]CpG¡^¡v¬O¥»¬ã¨sµo²{®ð³Ý§K¬Ì½Õ±±¸Ìªº«n«H¸¹¡C¡]³¯¦pÀ[¡þ¥x¥_³ø¾É¡^
¨Ó·½¡G§K¬Ì½Õ±±ªvÀøÃþ©T¾J§ÜÃÄ©Ê®ð³Ý ·½¦Û«C¬Kµkµß
¥X³B¡G°·±d¶Ç´C